THC Therapeutics, Inc.
THCT
$0.00
$0.000.00%
OTC PK
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 574.80K | 253.10K | 441.60K | 494.00K | 972.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 574.80K | 253.10K | 441.60K | 494.00K | 972.20K |
| Operating Income | -574.80K | -253.10K | -441.60K | -494.00K | -972.20K |
| Income Before Tax | -562.80K | -573.00K | 1.68M | -386.90K | -1.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.56 | -0.57 | 1.68 | -0.39 | 0.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -562.80K | -573.00K | 1.68M | -386.90K | -1.80K |
| EBIT | -574.80K | -253.10K | -441.60K | -494.00K | -972.20K |
| EBITDA | -573.40K | -251.70K | -440.20K | -492.50K | -970.20K |
| EPS Basic | -0.02 | -0.02 | 0.05 | -0.01 | 0.00 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.03 | -0.01 | 0.00 |
| EPS Diluted | -0.02 | -0.02 | 0.05 | -0.01 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.03 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 136.93M | 131.34M | 131.22M | 131.34M | 130.84M |
| Average Diluted Shares Outstanding | 136.93M | 131.34M | 131.22M | 131.34M | 130.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |